Tanios S. Bekaii-Saab, MD, FACP of Mayo Clinic gives an overview of his first presentation, which focused on the availability of new novel agents and therapies for managing patients with metastatic colorectal cancer. He discusses the uses of HER2, BRAF, and Immunotherapy. This was recorded at the 2017 Great Debates and Updates in GI Malignancies in New York, NY.
Availability of Novel Targets for Metastatic Colorectal Cancer
